المؤلفون: Stamenkovic V; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA., Lautz JD; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA., Harsh FM; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA., Smith SEP; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA. seps@uw.edu.; Department of Pediatrics, University of Washington, Seattle, WA, USA. seps@uw.edu.; Graduate Program in Neuroscience, University of Washington, Seattle, WA, USA. seps@uw.edu.

المصدر: Molecular psychiatry [Mol Psychiatry] 2024 May; Vol. 29 (5), pp. 1392-1405. Date of Electronic Publication: 2024 Jan 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5578 (Electronic) Linking ISSN: 13594184 NLM ISO Abbreviation: Mol Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Fragile X Syndrome*/metabolism , Fragile X Syndrome*/drug therapy , Fragile X Mental Retardation Protein*/metabolism , Fragile X Mental Retardation Protein*/genetics , Disease Models, Animal* , src-Family Kinases*/metabolism , Benzodioxoles*/pharmacology , Proto-Oncogene Proteins c-fyn*/metabolism , Neurons*/metabolism , Neurons*/drug effects, Animals ; Mice ; Male ; Receptors, Metabotropic Glutamate/metabolism ; Signal Transduction/drug effects ; Phenotype ; Synapses/metabolism ; Synapses/drug effects ; Protein Interaction Maps/drug effects ; Receptors, N-Methyl-D-Aspartate/metabolism ; Mice, Inbred C57BL ; Mice, Knockout ; Cerebral Cortex/metabolism ; Cerebral Cortex/drug effects ; Quinazolines